Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
Academic Article
Publication Date:
2019
Short description:
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up / Fradet, Y., Bellmunt, J., Vaughn, D.j., Lee, J.l., Fong, L., Vogelzang, N.j., Climent, M.a., Petrylak, D.p., Choueiri, T.k., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.i., Culine, S., Sternberg, C.n., Nam, K., Frenkl, T.l., Perini, R.f., de Wit, R., Bajorin, D.f.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 30:6(2019), pp. 970-976. [10.1093/annonc/mdz127]
Iris type:
1.1 Articolo in rivista
List of contributors:
Fradet, Y; Bellmunt, J; Vaughn, Dj; Lee, Jl; Fong, L; Vogelzang, Nj; Climent, Ma; Petrylak, Dp; Choueiri, Tk; Necchi, A; Gerritsen, W; Gurney, H; Quinn, Di; Culine, S; Sternberg, Cn; Nam, K; Frenkl, Tl; Perini, Rf; de Wit, R; Bajorin, Df
Published in: